Merging care and prevention

Preventive properties of antiretroviral drugs and HIV chronification in the case of Switzerland

Datos Bibliográficos

ID18995231
AutoresN Genre (0000-0003-1458-4441, Institut des Sciences Sociales, Université de Lausanne, Lausanne, Suisse, autor de correspondencia), Francesco Panese (0000-0002-7460-2018, Institut des Sciences Sociales, Université de Lausanne, Lausanne, Suisse)
Año2022
Volumen29
Número1
Páginas14-28
Fecha de publicación2022-01-02
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaAnthropology and Medicine (JOURNAL)
Identificadores de la revistaISSN: 1364-8470 • E-ISSN: 1469-2910
EditorialInforma UK Limited (PUBLISHER • GB)
DOI10.1080/13648470.2021.1949891
PMID34544292
OpenAlexW3200081343
IdiomaEN
Citas recibidas1
Referencias citadas37

Medication is closely involved in the subjective experience of chronic diseases, but also in the chronification process of illnesses which is described in this paper in the specific case of HIV. The development of antiretroviral drugs (ARVs) and the progressive recognition of their potential dual use as treatment as prevention (TasP) and pre-exposure prophylaxis (PrEP) reshape the experience of HIV and its transmission. Acknowledging the importance of a socioanthropological approach to drugs, this paper highlights how therapeutic strategies of treatment and prevention currently shape the process of HIV chronification and its experience for people concerned with ARVs in Switzerland, whether they are seropositive patients on lifelong treatment or seronegative people affected by the preventive properties of drugs

Antiretroviral therapy · Family medicine · Intensive care medicine · Treatment as prevention · Viral load · African Studies and Ethnography · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine